Clinical outcomes of dose modification during pirfenidone treatment for IPF: A nationwide post-marketing surveillance study

• Hoofdauteurs: Jieun Kang (Auteur), Man Pyo Chung (Auteur), Moo Suk Park (Auteur), In Jae Oh (Auteur), Heung Bum Lee (Auteur), Young Whan Kim (Auteur), Jong Sun Park (Auteur), Soo Taek Uh (Auteur), Yun Seong Kim (Auteur), Yangjin Jegal (Auteur), Jin Woo Song (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2023-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background: Pirfenidone, an antifibrotic medication approved for the treatment of idiopathic pulmonary fibrosis (IPF), often requires dose reduction owing to adverse events. In this study, we evaluated if pirfenidone's reduced dose has any impact on clinical outcomes in patients with IPF.Method...